methyl 4-(6-{4-[(anilinocarbonyl)amino]phenyl}-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate

ID: ALA1098244

PubChem CID: 44605038

Max Phase: Preclinical

Molecular Formula: C29H32N8O4

Molecular Weight: 556.63

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)Nc5ccccc5)cc4)nc32)CC1

Standard InChI:  InChI=1S/C29H32N8O4/c1-40-29(39)36-13-11-23(12-14-36)37-27-24(19-30-37)26(35-15-17-41-18-16-35)33-25(34-27)20-7-9-22(10-8-20)32-28(38)31-21-5-3-2-4-6-21/h2-10,19,23H,11-18H2,1H3,(H2,31,32,38)

Standard InChI Key:  FIUDAJSOKHKCEH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 41 46  0  0  0  0  0  0  0  0999 V2000
   15.5583  -17.9994    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5571  -18.8275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2726  -19.2407    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.2708  -17.5862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9868  -17.9958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9917  -18.8275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7843  -19.0799    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2693  -18.4041    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.7764  -17.7341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8437  -19.2401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1285  -18.8249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1323  -20.4764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8444  -20.0624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2683  -16.7605    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.9802  -16.3485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9797  -15.5264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2651  -15.1118    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.5495  -15.5256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5483  -16.3539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1912  -19.7927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7746  -20.5010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1808  -21.2132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0025  -21.2176    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.4160  -20.5038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0074  -19.7945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4125  -20.0631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4107  -19.2384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4128  -21.9342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6983  -20.4777    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9823  -20.0664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9804  -19.2407    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.2682  -20.4809    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.5520  -20.0697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9976  -22.6478    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.2386  -21.9370    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.6490  -22.6535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5539  -19.2446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8387  -18.8334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1235  -19.2480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1282  -20.0780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8439  -20.4854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 17 18  1  0
 18 19  1  0
  9  5  1  0
  7 20  1  0
  4  1  1  0
 20 21  1  0
  5  6  1  0
 21 22  1  0
 10 11  2  0
 22 23  1  0
 11 27  1  0
 23 24  1  0
 24 25  1  0
 25 20  1  0
 26 27  2  0
 26 12  1  0
  2  3  1  0
 12 13  2  0
 23 28  1  0
 13 10  1  0
 26 29  1  0
  2 10  1  0
 29 30  1  0
  3  6  2  0
 30 31  2  0
  4 14  1  0
 30 32  1  0
 14 15  1  0
 32 33  1  0
  1  2  2  0
 28 34  2  0
  5  4  2  0
 28 35  1  0
  6  7  1  0
 35 36  1  0
  7  8  1  0
 33 37  2  0
  8  9  2  0
 37 38  1  0
 14 19  1  0
 38 39  2  0
 15 16  1  0
 39 40  1  0
 16 17  1  0
 40 41  2  0
 41 33  1  0
M  END

Associated Targets(Human)

CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MTOR Tclin Serine/threonine-protein kinase mTOR (13850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CA Tclin PI3-kinase p110-alpha subunit (12269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNCaP (8286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 556.63Molecular Weight (Monoisotopic): 556.2547AlogP: 4.38#Rotatable Bonds: 5
Polar Surface Area: 126.74Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.32CX Basic pKa: 4.01CX LogP: 4.02CX LogD: 4.02
Aromatic Rings: 4Heavy Atoms: 41QED Weighted: 0.37Np Likeness Score: -1.82

References

1. Verheijen JC, Richard DJ, Curran K, Kaplan J, Lefever M, Nowak P, Malwitz DJ, Brooijmans N, Toral-Barza L, Zhang WG, Lucas J, Hollander I, Ayral-Kaloustian S, Mansour TS, Yu K, Zask A..  (2009)  Discovery of 4-morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as highly potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 6-aryl substituent.,  52  (24): [PMID:19894727] [10.1021/jm9013828]

Source